Clinical Trials in Psychopharmacology: A Better Brain

The authors take a critical look at recent developments and present a series of trenchant and challenging observations.

Although clinical trials were virtually unheard of in psychiatry for many years, they are now the gold standard for judging whether drugs are safe and useful. But should they be? What is the true status of clinical trials? Even when they ostensibly demonstrate a benefit of a certain treatment, the strict patient selection criteria, poor compliance and high drop-out rate leave the conclusions open to question. Are the new treatments really better or more cost-effective than the old? Do they have fewer side effects?

Clearly written, this book provides immediate access to new developments across the spectrum of drug testing. It's provocative reading for psychiatrists, pharmacologists and all those interested in improved drug treatments for patients with mental illness. It raises questions about the conduct of trials and the credibility of their outcomes that are relevant not just in psychiatry but all areas of medicine, and discusses the ethical problems in assessing outcomes

Platform:

OvidSP

Publisher:

Wiley

Product Type:

Book

Author:

Hertzman, Marc; Adler, Lawrence

ISBN:

978-0-47-074076-7

Specialty:

• Psychopharmacology

Language:

English

Edition:

2nd

Pages:

406

Publication Year:

2010

Doody Core Title Score:

• ()